Commentary

Patients with agoraphobia are showing strength, resilience during the pandemic


 

Understanding why functioning might be better

I attribute the improved functioning I am seeing to five factors:

1. Some people with agoraphobia may find that physical distancing provides relief, because it discourages situations that may trigger fear.

2. Staying in their homes can make people with agoraphobia feel like part of mainstream America, rather than outside the norm. Also, they become egosyntonic, and sense both acceptance and comfort in their homes.

3. Isolating, staying home, and avoidance behavior is now applauded and has become the norm for the entire population. Thus, people with agoraphobia might feel heightened self-esteem.

4. Since many people have been staying in for the most part, people with agoraphobia do not feel they are missing out by staying in. As a result, they are experiencing less depression.

5. Normally, leaving home, traveling, and sitting in the doctor’s office for therapy causes great anxiety for my patients with agoraphobia. Now, I treat my patients through the use of telemedicine or by phone, and thus, patients are more relaxed and calm because they do not have to leave their homes and travel to my office. Thus, patients can avoid this dreaded anxiety trigger.

It might have been logical to assume that patients living with agoraphobia would be negatively affected by the pandemic, and experience increased feelings of anxiety and/or panic attacks – since the pandemic forced those with the illness to face fearful situations from which they cannot escape.

Fortunately, my agoraphobia patients have fared very well. They have remained on their prescribed medications and have adapted well to phone and telemedicine therapy. In fact, the adjustment of my patients with agoraphobia to the stringent mitigation measures surpassed the adjustment of my other patients. These patients with agoraphobia have proved to be a strong and resilient group in the face of extreme stress.

Dr. Cohen, who is married to Nancy S. Cohen, is board-certified in psychiatry and has had a private practice in Philadelphia for more than 35 years. His areas of specialty include agoraphobia, sports psychiatry, depression, and substance abuse. In addition, Dr. Cohen is a former professor of psychiatry, family medicine, and otolaryngology at Thomas Jefferson University in Philadelphia. He has no conflicts of interest. Ms. Cohen holds an MBA from Temple University in Philadelphia with a focus on health care administration. Previously, Ms. Cohen was an associate administrator at Hahnemann University Hospital and an executive at the Health Services Council, both in Philadelphia. She currently writes biographical summaries of notable 18th- and 19th-century women. Ms. Cohen has no disclosures.

Pages

Recommended Reading

Buprenorphine for OUD may also mitigate risk with concomitant benzo, Z-drug use
MDedge Internal Medicine
Tips to share with patients feeling vaccine FOMO
MDedge Internal Medicine
New data on worldwide mental health impact of COVID-19
MDedge Internal Medicine
Child abuse tied to persistent inflammation in later life
MDedge Internal Medicine
Adult separation anxiety raises suicidality risk
MDedge Internal Medicine
Shedding the super doctor myth
MDedge Internal Medicine
Chauvin guilty verdict: Now it’s time to get to work
MDedge Internal Medicine
What I want people to know about the Chauvin verdict
MDedge Internal Medicine
The cloudy role of cannabis as a neuropsychiatric treatment
MDedge Internal Medicine
National poll shows ‘concerning’ impact of COVID on Americans’ mental health
MDedge Internal Medicine